Prof Luca Pani

MD | University of Modena and Reggio Emilia, Italy; University of Miami, USA

Luca Pani, MD is Professor of Clinical Psychiatry, University of Miami, and Professor of Pharmacology and Clinical Pharmacology, University of Modena and Reggio Emilia in Italy. He is also VP for Regulatory Strategy and Market Access Innovation at WCG Clinical, Princeton and Chief Clinical Operations and Strategic Development for Relmada Therapeutics, Coral Gables, USA. As former Director General of the Italian Medicines Agency (AIFA, 2011-2016) and member of the Committee for Human Medicines (CHMP) and the Scientific Advices Working Party (SAWP) for the European Medicines Agency (EMA) in London (2010-2017), he is a recognized expert in pharmacology, clinical psychiatry and regulatory science with particular emphasis on health technology assessment linked with novel negotiation strategies for the reimbursement of precision medicines.